Table 1.
Donor | Acceptor | N | Pretreatment | Ang II (min) | AT1R lifetime τm (ns) |
---|---|---|---|---|---|
AT1R- EGFP | None | 6 | None | 0 | 2.33±0.07 |
4 | 5 | 2.33±0.11 | |||
5 | 30 | 2.31±0.08 | |||
AT1R- EGFP | Alexa 555 alone | 5 | None | 0 | 2.33±0.04 |
4 | 5 | 2.31±0.11 | |||
5 | 30 | 2.32±0.28 | |||
EGFP alone | None | 6 | None | 0 | 2.56±0.30 |
5 | 5 | 2.56±0.27 | |||
6 | 30 | 2.57±0.33 | |||
EGFP alone | Alexa 555 alone | 5 | None | 0 | 2.61±0.41 |
7 | 5 | 2.59±0.35 | |||
7 | 30 | 2.53±0.19 |